Nanocarry Therapeutics Revenue

Biotechnology Research • Pinchas Sapir 3, Weizmann Science Park, Israel • 11-20 Employees

Nanocarry Therapeutics revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	No funding

Key Contacts at Nanocarry Therapeutics

Oshra Betzer

Founder & Coo

Revital Mandil Levin

Ceo & Founder

Rachela Popovtzer

Founder & Cto At Nanocarry

Company overview

Headquarters	Pinchas Sapir 3, Weizmann Science Park, Israel
Website	nanocarry.com
NAICS	541714
Keywords	Drug Delivery, Nanotechnology, Nanoparticles, Immuno-Oncology, Antibodies, Biologics, Neurodegenerative Disease, Blood Brain Barrier
Founded	2021
Employees	11-20
Socials

Nanocarry Therapeutics Email Formats

Nanocarry Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@nanocarry.com), used 54.5% of the time.

Format	Example	Percentage
{first name}	john@nanocarry.com	54.5%
{first initial}	j@nanocarry.com	45.5%

About Nanocarry Therapeutics

Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Entry

Senior

Employees by Department

Nanocarry Therapeutics has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Nanocarry Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-03-24	3	N/A

Funding Insights

Number of funding rounds

Nanocarry Therapeutics Tech Stack

Discover the technologies and tools that power Nanocarry Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Slick

JavaScript libraries

jQuery UI

JavaScript libraries

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

Frequently asked questions

Nanocarry Therapeutics is located in Pinchas Sapir 3, Weizmann Science Park, IL.

Nanocarry Therapeutics generates an estimated annual revenue of $941,105. This revenue figure reflects the company's market position and business performance in its industry.

Nanocarry Therapeutics has an estimated valuation of $3,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Nanocarry Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Nanocarry Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Nanocarry Therapeutics

Oshra Betzer

Founder & Coo

Revital Mandil Levin

Ceo & Founder

Rachela Popovtzer

Founder & Cto At Nanocarry

4.8

40,000 users